CN Stock MarketDetailed Quotes

002603 Shijiazhuang Yiling Pharmaceutical

Watchlist
  • 18.94
  • -0.64-3.27%
Noon Break Apr 29 11:30 CST
31.64BMarket Cap69.63P/E (TTM)

Shijiazhuang Yiling Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-35.89%2.52B
-17.67%10.32B
7.91%8.57B
21.99%6.79B
44.56%3.93B
23.88%12.53B
-2.04%7.95B
-5.59%5.57B
-25.80%2.72B
15.19%10.12B
Operating revenue
-35.89%2.52B
-17.67%10.32B
7.91%8.57B
21.99%6.79B
44.56%3.93B
23.88%12.53B
-2.04%7.95B
-5.59%5.57B
-25.80%2.72B
15.19%10.12B
Other operating revenue
----
-73.27%3.48M
----
-64.36%2.85M
----
113.13%13.04M
----
156.01%7.99M
----
-27.35%6.12M
Total operating cost
-13.10%2.16B
-9.80%8.72B
5.70%6.58B
14.62%4.9B
16.31%2.49B
12.93%9.67B
-7.39%6.22B
-10.74%4.28B
-24.98%2.14B
16.57%8.56B
Operating cost
-11.21%1.22B
-2.92%4.41B
10.82%3.34B
23.65%2.6B
29.96%1.38B
23.35%4.54B
3.89%3.02B
1.03%2.1B
-19.08%1.06B
18.04%3.68B
Operating tax surcharges
-3.89%44.32M
-33.58%135.13M
-11.46%110.22M
-7.89%78.69M
-4.21%46.12M
46.99%203.45M
16.40%124.49M
9.96%85.43M
-10.24%48.14M
1.56%138.41M
Operating expense
-22.41%567.76M
-17.00%2.7B
-3.74%2.09B
3.06%1.52B
-2.10%731.73M
-5.10%3.26B
-22.34%2.17B
-27.71%1.48B
-36.84%747.42M
13.14%3.43B
Administration expense
-17.51%138.16M
-3.30%592.04M
21.97%430.36M
28.06%294.89M
39.37%167.48M
23.23%612.22M
1.65%352.84M
4.50%230.27M
4.64%120.17M
24.10%496.82M
Financial expense
1,603.45%8.44M
32.37%26.37M
80.26%9.45M
-41.13%4.73M
-91.07%495.21K
15.02%19.92M
-80.78%5.24M
-13.90%8.04M
116.41%5.55M
1,042.94%17.32M
-Interest expense (Financial expense)
58.06%9.55M
15.11%38.9M
12.91%25.87M
-0.55%15.8M
-26.68%6.04M
-0.53%33.8M
-43.71%22.91M
-16.53%15.89M
35.73%8.24M
209.93%33.97M
-Interest Income (Financial expense)
74.67%-2.08M
-24.80%-16.09M
7.74%-17.16M
-17.67%-11.73M
-127.02%-8.2M
36.93%-12.9M
-13.80%-18.6M
16.01%-9.97M
20.83%-3.61M
-44.65%-20.45M
Research and development
9.55%180.59M
-17.33%853.19M
7.62%593.71M
7.64%402.61M
4.29%164.84M
30.28%1.03B
2.62%551.68M
4.03%374.04M
-15.73%158.06M
21.05%792.16M
Credit Impairment Loss
-315.75%-3.38M
-40.01%-23.7M
-156.05%-10.49M
-37.89%-2.74M
605.36%1.57M
55.11%-16.93M
19.44%-4.1M
11.84%-1.99M
-141.80%-309.8K
-86.24%-37.71M
Asset Impairment Loss
89.28%-1.56M
67.39%-35.36M
-528.23%-15.92M
-151.78%-15.92M
---14.54M
-278.74%-108.43M
---2.53M
---6.32M
----
50.77%-28.63M
Other net revenue
185.19%32.09M
596.40%180.71M
310.88%130.8M
274.68%51.73M
559.33%11.25M
-403.68%-36.4M
-44.63%31.83M
-69.44%13.81M
-82.61%1.71M
864.14%11.99M
Fair value change income
22.69%12.95M
110.07%39.35M
3,200.46%44.43M
2,586.99%27.7M
2,279.16%10.56M
910.90%18.73M
0.00%1.35M
15.04%1.03M
-80.78%443.75K
-64.56%1.85M
Invest income
187.12%3.81M
458.97%25.95M
94.38%-389.59K
149.87%2.56M
-13.01%-4.38M
69.56%-7.23M
-371.14%-6.93M
-377.43%-5.14M
-1,203.62%-3.87M
-197.44%-23.75M
-Including: Investment income associates
---2.9K
-404.37%-15.06K
---10.01K
---9.85K
----
---2.99K
----
----
----
----
Asset deal income
54.61%-58.22K
73.67%-819.3K
49.88%-1.49M
63.18%-951.69K
71.35%-128.28K
-23.64%-3.11M
-284.25%-2.96M
-267.27%-2.58M
66.27%-447.7K
-1,902.33%-2.52M
Other revenue
11.81%20.32M
117.58%175.28M
143.85%114.65M
42.60%41.07M
208.31%18.17M
-21.58%80.56M
-20.91%47.01M
-36.53%28.8M
-23.87%5.89M
118.17%102.74M
Operating profit
-73.13%391.39M
-37.10%1.78B
21.25%2.13B
48.93%1.94B
149.70%1.46B
80.33%2.83B
21.02%1.76B
13.39%1.3B
-29.29%583.45M
9.11%1.57B
Add:Non operating Income
-47.76%826.48K
0.86%8.44M
-10.37%3.86M
102.52%2.76M
113.72%1.58M
-23.37%8.37M
-50.36%4.31M
-69.39%1.36M
-56.65%740.25K
980.48%10.92M
Less:Non operating expense
949.44%23.77M
81.66%104.06M
-51.71%26.48M
-77.36%7.73M
-84.80%2.26M
118.02%57.28M
314.46%54.85M
210.17%34.13M
502.24%14.9M
58.51%26.27M
Total profit
-74.70%368.46M
-39.43%1.68B
23.52%2.11B
52.38%1.93B
155.79%1.46B
78.97%2.78B
17.91%1.71B
11.17%1.27B
-30.95%569.3M
9.23%1.55B
Less:Income tax cost
-73.88%66.54M
-19.62%339.91M
20.19%352.15M
49.14%330.34M
196.95%254.75M
99.39%422.87M
31.20%292.99M
25.13%221.5M
-42.57%85.79M
2.19%212.09M
Net profit
-74.87%301.92M
-42.98%1.34B
24.21%1.75B
53.07%1.6B
148.48%1.2B
75.74%2.36B
15.48%1.41B
8.61%1.05B
-28.37%483.51M
10.43%1.34B
Net profit from continuing operation
-74.87%301.92M
-42.98%1.34B
24.21%1.75B
53.07%1.6B
148.48%1.2B
75.74%2.36B
15.48%1.41B
8.61%1.05B
-28.37%483.51M
10.43%1.34B
Less:Minority Profit
-86.37%-2.01M
-62.08%-8.08M
-115.41%-4.75M
-127.02%-2.97M
-33.20%-1.08M
-124.08%-4.98M
-153.12%-2.2M
-1,137.88%-1.31M
-327.07%-808.96K
41.59%-2.22M
Net profit of parent company owners
-74.73%303.93M
-42.76%1.35B
24.35%1.76B
53.16%1.61B
148.29%1.2B
75.82%2.36B
15.58%1.41B
8.76%1.05B
-28.22%484.32M
10.27%1.34B
Earning per share
Basic earning per share
-74.73%0.1819
-42.76%0.8095
24.36%1.0527
53.17%0.9613
148.21%0.7198
75.81%1.4142
15.58%0.8465
8.75%0.6276
-28.18%0.29
10.27%0.8044
Diluted earning per share
-74.73%0.1819
-42.76%0.8095
24.36%1.0527
53.17%0.9613
148.21%0.7198
75.81%1.4142
15.58%0.8465
8.75%0.6276
-28.18%0.29
10.27%0.8044
Other composite income
-109.64%-33.17K
-75.74%604.59K
-60.16%894.04K
-7.73%993.76K
308.67%344.14K
495.75%2.49M
1,580.59%2.24M
690.49%1.08M
-168.16%-164.92K
87.92%-629.84K
Other composite income of parent company owners
-109.64%-33.17K
-75.74%604.59K
-60.16%894.04K
-7.73%993.76K
308.67%344.14K
495.75%2.49M
1,580.59%2.24M
690.49%1.08M
-168.16%-164.92K
87.92%-629.84K
Total composite income
-74.88%301.89M
-43.02%1.34B
24.07%1.75B
53.01%1.6B
148.64%1.2B
76.01%2.36B
15.65%1.41B
8.74%1.05B
-28.42%483.34M
10.85%1.34B
Total composite income of parent company owners
-74.74%303.89M
-42.80%1.35B
24.21%1.76B
53.10%1.61B
148.45%1.2B
76.09%2.37B
15.75%1.42B
8.89%1.05B
-28.27%484.15M
10.69%1.34B
Total composite income of minority owners
-86.37%-2.01M
-62.08%-8.08M
-115.41%-4.75M
-127.02%-2.97M
-33.20%-1.08M
-124.08%-4.98M
-153.12%-2.2M
-1,137.88%-1.31M
-327.07%-808.96K
41.59%-2.22M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Zhongqin Wanxin Certified Public Accountants (Special General Partnership)
--
--
--
Zhongqin Wanxin Certified Public Accountants (Special General Partnership)
--
--
--
Zhongqin Wanxin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -35.89%2.52B-17.67%10.32B7.91%8.57B21.99%6.79B44.56%3.93B23.88%12.53B-2.04%7.95B-5.59%5.57B-25.80%2.72B15.19%10.12B
Operating revenue -35.89%2.52B-17.67%10.32B7.91%8.57B21.99%6.79B44.56%3.93B23.88%12.53B-2.04%7.95B-5.59%5.57B-25.80%2.72B15.19%10.12B
Other operating revenue -----73.27%3.48M-----64.36%2.85M----113.13%13.04M----156.01%7.99M-----27.35%6.12M
Total operating cost -13.10%2.16B-9.80%8.72B5.70%6.58B14.62%4.9B16.31%2.49B12.93%9.67B-7.39%6.22B-10.74%4.28B-24.98%2.14B16.57%8.56B
Operating cost -11.21%1.22B-2.92%4.41B10.82%3.34B23.65%2.6B29.96%1.38B23.35%4.54B3.89%3.02B1.03%2.1B-19.08%1.06B18.04%3.68B
Operating tax surcharges -3.89%44.32M-33.58%135.13M-11.46%110.22M-7.89%78.69M-4.21%46.12M46.99%203.45M16.40%124.49M9.96%85.43M-10.24%48.14M1.56%138.41M
Operating expense -22.41%567.76M-17.00%2.7B-3.74%2.09B3.06%1.52B-2.10%731.73M-5.10%3.26B-22.34%2.17B-27.71%1.48B-36.84%747.42M13.14%3.43B
Administration expense -17.51%138.16M-3.30%592.04M21.97%430.36M28.06%294.89M39.37%167.48M23.23%612.22M1.65%352.84M4.50%230.27M4.64%120.17M24.10%496.82M
Financial expense 1,603.45%8.44M32.37%26.37M80.26%9.45M-41.13%4.73M-91.07%495.21K15.02%19.92M-80.78%5.24M-13.90%8.04M116.41%5.55M1,042.94%17.32M
-Interest expense (Financial expense) 58.06%9.55M15.11%38.9M12.91%25.87M-0.55%15.8M-26.68%6.04M-0.53%33.8M-43.71%22.91M-16.53%15.89M35.73%8.24M209.93%33.97M
-Interest Income (Financial expense) 74.67%-2.08M-24.80%-16.09M7.74%-17.16M-17.67%-11.73M-127.02%-8.2M36.93%-12.9M-13.80%-18.6M16.01%-9.97M20.83%-3.61M-44.65%-20.45M
Research and development 9.55%180.59M-17.33%853.19M7.62%593.71M7.64%402.61M4.29%164.84M30.28%1.03B2.62%551.68M4.03%374.04M-15.73%158.06M21.05%792.16M
Credit Impairment Loss -315.75%-3.38M-40.01%-23.7M-156.05%-10.49M-37.89%-2.74M605.36%1.57M55.11%-16.93M19.44%-4.1M11.84%-1.99M-141.80%-309.8K-86.24%-37.71M
Asset Impairment Loss 89.28%-1.56M67.39%-35.36M-528.23%-15.92M-151.78%-15.92M---14.54M-278.74%-108.43M---2.53M---6.32M----50.77%-28.63M
Other net revenue 185.19%32.09M596.40%180.71M310.88%130.8M274.68%51.73M559.33%11.25M-403.68%-36.4M-44.63%31.83M-69.44%13.81M-82.61%1.71M864.14%11.99M
Fair value change income 22.69%12.95M110.07%39.35M3,200.46%44.43M2,586.99%27.7M2,279.16%10.56M910.90%18.73M0.00%1.35M15.04%1.03M-80.78%443.75K-64.56%1.85M
Invest income 187.12%3.81M458.97%25.95M94.38%-389.59K149.87%2.56M-13.01%-4.38M69.56%-7.23M-371.14%-6.93M-377.43%-5.14M-1,203.62%-3.87M-197.44%-23.75M
-Including: Investment income associates ---2.9K-404.37%-15.06K---10.01K---9.85K-------2.99K----------------
Asset deal income 54.61%-58.22K73.67%-819.3K49.88%-1.49M63.18%-951.69K71.35%-128.28K-23.64%-3.11M-284.25%-2.96M-267.27%-2.58M66.27%-447.7K-1,902.33%-2.52M
Other revenue 11.81%20.32M117.58%175.28M143.85%114.65M42.60%41.07M208.31%18.17M-21.58%80.56M-20.91%47.01M-36.53%28.8M-23.87%5.89M118.17%102.74M
Operating profit -73.13%391.39M-37.10%1.78B21.25%2.13B48.93%1.94B149.70%1.46B80.33%2.83B21.02%1.76B13.39%1.3B-29.29%583.45M9.11%1.57B
Add:Non operating Income -47.76%826.48K0.86%8.44M-10.37%3.86M102.52%2.76M113.72%1.58M-23.37%8.37M-50.36%4.31M-69.39%1.36M-56.65%740.25K980.48%10.92M
Less:Non operating expense 949.44%23.77M81.66%104.06M-51.71%26.48M-77.36%7.73M-84.80%2.26M118.02%57.28M314.46%54.85M210.17%34.13M502.24%14.9M58.51%26.27M
Total profit -74.70%368.46M-39.43%1.68B23.52%2.11B52.38%1.93B155.79%1.46B78.97%2.78B17.91%1.71B11.17%1.27B-30.95%569.3M9.23%1.55B
Less:Income tax cost -73.88%66.54M-19.62%339.91M20.19%352.15M49.14%330.34M196.95%254.75M99.39%422.87M31.20%292.99M25.13%221.5M-42.57%85.79M2.19%212.09M
Net profit -74.87%301.92M-42.98%1.34B24.21%1.75B53.07%1.6B148.48%1.2B75.74%2.36B15.48%1.41B8.61%1.05B-28.37%483.51M10.43%1.34B
Net profit from continuing operation -74.87%301.92M-42.98%1.34B24.21%1.75B53.07%1.6B148.48%1.2B75.74%2.36B15.48%1.41B8.61%1.05B-28.37%483.51M10.43%1.34B
Less:Minority Profit -86.37%-2.01M-62.08%-8.08M-115.41%-4.75M-127.02%-2.97M-33.20%-1.08M-124.08%-4.98M-153.12%-2.2M-1,137.88%-1.31M-327.07%-808.96K41.59%-2.22M
Net profit of parent company owners -74.73%303.93M-42.76%1.35B24.35%1.76B53.16%1.61B148.29%1.2B75.82%2.36B15.58%1.41B8.76%1.05B-28.22%484.32M10.27%1.34B
Earning per share
Basic earning per share -74.73%0.1819-42.76%0.809524.36%1.052753.17%0.9613148.21%0.719875.81%1.414215.58%0.84658.75%0.6276-28.18%0.2910.27%0.8044
Diluted earning per share -74.73%0.1819-42.76%0.809524.36%1.052753.17%0.9613148.21%0.719875.81%1.414215.58%0.84658.75%0.6276-28.18%0.2910.27%0.8044
Other composite income -109.64%-33.17K-75.74%604.59K-60.16%894.04K-7.73%993.76K308.67%344.14K495.75%2.49M1,580.59%2.24M690.49%1.08M-168.16%-164.92K87.92%-629.84K
Other composite income of parent company owners -109.64%-33.17K-75.74%604.59K-60.16%894.04K-7.73%993.76K308.67%344.14K495.75%2.49M1,580.59%2.24M690.49%1.08M-168.16%-164.92K87.92%-629.84K
Total composite income -74.88%301.89M-43.02%1.34B24.07%1.75B53.01%1.6B148.64%1.2B76.01%2.36B15.65%1.41B8.74%1.05B-28.42%483.34M10.85%1.34B
Total composite income of parent company owners -74.74%303.89M-42.80%1.35B24.21%1.76B53.10%1.61B148.45%1.2B76.09%2.37B15.75%1.42B8.89%1.05B-28.27%484.15M10.69%1.34B
Total composite income of minority owners -86.37%-2.01M-62.08%-8.08M-115.41%-4.75M-127.02%-2.97M-33.20%-1.08M-124.08%-4.98M-153.12%-2.2M-1,137.88%-1.31M-327.07%-808.96K41.59%-2.22M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Zhongqin Wanxin Certified Public Accountants (Special General Partnership)------Zhongqin Wanxin Certified Public Accountants (Special General Partnership)------Zhongqin Wanxin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg